<p>Naive T cells are maintained under a quiescent state, and their exit from quiescence is a hallmark of antigen stimulation. Here we identify the RNA binding protein La-related protein 4 (LARP4) as an important checkpoint regulator of quiescence exit in naive CD4<sup>+</sup> T cells. Conditional knockout of LARP4 in naive CD4<sup>+</sup> T cells leads to an enhanced quiescence state and/or dampened quiescence exit due to altered stability of several messenger RNAs important for T-cell activation. The differentiation of naive CD4<sup>+</sup> T cells into helper T-cell subsets is also impaired after conditional knockout, leading to ameliorated autoimmune and allergic responses. Lastly, we design a peptide inhibitor of LARP4 (LIPEP), and treatment with LIPEP could perfectly mimic LARP4 deficiency and alleviate the severity of autoimmune and allergic diseases in the corresponding mouse models. Our study reveals a link between RNA stability and CD4<sup>+</sup> T-cell homeostasis/adaptive activation, highlighting the potential of LARP4 as a preventative and therapeutic target for autoimmune and allergic diseases although at quite high doses.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Inhibition of LARP4-mediated quiescence exit of naive CD4+ T cells ameliorates autoimmune and allergic diseases

  • Jian Zhou,
  • Di Yang,
  • Chao Han,
  • Hui Dong,
  • Shufeng Wang,
  • Xiang Li,
  • Jun Hu,
  • Cui Wang,
  • Jie Luo,
  • Zhiyuan Wei,
  • Taiping Liu,
  • Shuai Xu,
  • Chen Xu,
  • Yiwei Zhang,
  • Xian Wang,
  • Yuanyu Deng,
  • Baiqing Li,
  • Ruihan Mao,
  • Mingyang Zhang,
  • Yi Sun,
  • Xinyuan Zhou,
  • Lilin Ye,
  • Bing Ni,
  • Jun Zhu,
  • Juan Li,
  • Jingbo Zhang,
  • Tingting Zhao,
  • Xiangmei Chen,
  • Rong Lin,
  • Yi Zhang,
  • Yuzhang Wu,
  • Yi Tian

摘要

Naive T cells are maintained under a quiescent state, and their exit from quiescence is a hallmark of antigen stimulation. Here we identify the RNA binding protein La-related protein 4 (LARP4) as an important checkpoint regulator of quiescence exit in naive CD4+ T cells. Conditional knockout of LARP4 in naive CD4+ T cells leads to an enhanced quiescence state and/or dampened quiescence exit due to altered stability of several messenger RNAs important for T-cell activation. The differentiation of naive CD4+ T cells into helper T-cell subsets is also impaired after conditional knockout, leading to ameliorated autoimmune and allergic responses. Lastly, we design a peptide inhibitor of LARP4 (LIPEP), and treatment with LIPEP could perfectly mimic LARP4 deficiency and alleviate the severity of autoimmune and allergic diseases in the corresponding mouse models. Our study reveals a link between RNA stability and CD4+ T-cell homeostasis/adaptive activation, highlighting the potential of LARP4 as a preventative and therapeutic target for autoimmune and allergic diseases although at quite high doses.